NeuroDex develops blood based diagnostics for neurodegenerative disorders. Additionally, we assist and advance neurological research and development by making our one-of-a-kind platform available for collaborations. NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analyzing these.
| Website | https://neurodex.co |
| Employees | 16 (11 on RocketReach) |
| Founded | 2018 |
| Address | 27 Strathmore Rd, Natick, Massachusetts 01760, US |
| Phone | +1 973-648-8088 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Neurological Research, Neurological Development, Diagnostic Platform, Neurological Disease Research, Neurology Testing |
| Competitors | Motorola Solutions, Biogen, Eisai Co., Ltd., Salk Institute for Biological Studies, NeuroPace, Avid Radiopharmaceuticals, Alzheimer's Drug Discovery Foundation, CureMetrix, GENOOX, Axovant Sciences Ltd +31 more (view full list) |
Looking for a particular NeuroDex employee's phone or email?
Erez Eitan is the Chief Scientific Officer of NeuroDex.
11 people are employed at NeuroDex.
NeuroDex is based in Natick, Massachusetts.